IVVD vs. SABS
IVVD (Invivyd Inc.) and SABS (SAB Biotherapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, IVVD returned -4.41%/yr vs -21.42%/yr for SABS. At a 0.14 correlation, their price movements are largely independent.
Performance
IVVD vs. SABS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IVVD achieves a -62.16% return, which is significantly lower than SABS's 5.08% return.
IVVD
- 1D
- 2.21%
- 1M
- -15.04%
- YTD
- -62.16%
- 6M
- -66.62%
- 1Y
- 33.29%
- 3Y*
- -4.41%
- 5Y*
- —
- 10Y*
- —
SABS
- 1D
- -1.75%
- 1M
- 0.77%
- YTD
- 5.08%
- 6M
- 2.34%
- 1Y
- 119.55%
- 3Y*
- -21.42%
- 5Y*
- -47.61%
- 10Y*
- —
IVVD vs. SABS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IVVD Invivyd Inc. | -62.16% | 457.44% | -88.75% | 162.67% | -79.34% | -65.43% |
SABS SAB Biotherapeutics, Inc. | 5.08% | -1.43% | -44.81% | 16.55% | -92.45% | -21.10% |
Correlation
The correlation between IVVD and SABS is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Aug 6, 2021 | 0.14 |
Fundamentals
IVVD:
$289.42M
SABS:
$210.49M
IVVD:
-$0.40
SABS:
-$0.01
IVVD:
1.43
SABS:
0.93
IVVD:
$55.87M
SABS:
$0.00
IVVD:
$51.92M
SABS:
-$2.35M
IVVD:
-$79.85M
SABS:
$994.59K
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IVVD vs. SABS — Risk / Return Rank
IVVD
SABS
IVVD vs. SABS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invivyd Inc. (IVVD) and SAB Biotherapeutics, Inc. (SABS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IVVD | SABS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.17 | ||
| Sortino ratioReturn per unit of downside risk | -0.71 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.29 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.46 | 3.56 | -3.10 |
| Martin ratioReturn relative to average drawdown | 0.97 | 7.65 | -6.68 |
Loading charts...
Drawdowns
IVVD vs. SABS - Drawdown Comparison
The maximum IVVD drawdown since its inception was -99.36%, roughly equal to the maximum SABS drawdown of -99.01%. Use the drawdown chart below to compare losses from any high point for IVVD and SABS.
Loading charts...
Drawdown Indicators
| IVVD | SABS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.36% | -99.01% | -0.35% |
Max Drawdown (1Y)Largest decline over 1 year | -73.26% | -33.80% | -39.46% |
Max Drawdown (3Y)Largest decline over 3 years | -92.90% | -88.96% | -3.94% |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.01% | — |
Current DrawdownCurrent decline from peak | -98.33% | -96.50% | -1.83% |
Average DrawdownAverage peak-to-trough decline | -91.13% | -78.14% | -12.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.53% | 15.69% | +18.84% |
Volatility
IVVD vs. SABS - Volatility Comparison
Invivyd Inc. (IVVD) has a higher volatility of 25.46% compared to SAB Biotherapeutics, Inc. (SABS) at 21.76%. This indicates that IVVD's price experiences larger fluctuations and is considered to be riskier than SABS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IVVD | SABS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.46% | 21.76% | +3.70% |
Volatility (6M)Calculated over the trailing 6-month period | 69.43% | 45.35% | +24.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 141.07% | 85.65% | +55.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 178.37% | 112.38% | +65.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 178.37% | 108.46% | +69.91% |
Dividends
IVVD vs. SABS - Dividend Comparison
Neither IVVD nor SABS has paid dividends to shareholders.
Financials
IVVD vs. SABS - Financials Comparison
This section allows you to compare key financial metrics between Invivyd Inc. and SAB Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IVVD and SABS have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IVVD has higher volatility (25.46%) compared to SABS (21.76%). In terms of maximum drawdown, IVVD dropped -99.36% vs SABS's -99.01%.
SABS currently has the higher Sharpe Ratio (1.41 vs 0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IVVD and SABS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer